Loading insider details...
Beta
Latest Form 4 (May 29, 2026): Grant/Award of 6,250 IMMX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 29, 2026 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 6,250 | n/a |
| Jun 23, 2025 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 33,000 | n/a |
| Aug 20, 2024 | Immix Biopharma, Inc. (IMMX) | Purchase | 10,000 | $18.6K |
| Jun 21, 2024 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 33,000 | n/a |
| May 20, 2024 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 21,587 | n/a |
| Sep 15, 2023 | Immix Biopharma, Inc. (IMMX) | Purchase | 10,000 | $25.8K |
| Aug 14, 2023 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 20,000 | n/a |
| Jul 18, 2022 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 16,000 | n/a |
| Dec 20, 2021 | Immix Biopharma, Inc. (IMMX) | Conversion | 1,000,221 | $850.2K |